Pharmaceutical manufacturing has measurable ESG obligations. Sustaineve structures them.
Energy-intensive cleanroom operations, steam boilers, cold chain refrigerants, and purchased electricity create a well-defined Scope 1 and Scope 2 profile. BRSR Principle 6 requires annual GHG disclosure. Sustaineve calculates it from the data your GMP systems already track.
India's pharmaceutical sector is not in CCTS first-wave coverage — but BRSR mandatory filing, institutional investor ESG scoring, and supply chain due diligence from global pharma buyers create active compliance pressure now.
Emission Sources
Where pharma emissions come from.
Sustaineve handles every Scope 1 and Scope 2 source category for pharmaceutical manufacturing — with IPCC 2006 & 2019 factors and CEA state grid data pre-loaded.
Steam boilers
Coal, natural gas, biomass-fired boilers supplying process steam for reactors, sterilisation, and HVAC.
Diesel generators
Backup power and site utility generation — common in API manufacturing where grid reliability is critical.
Refrigerant leaks
Fugitive HFC emissions from cold storage, cold chain logistics, and process cooling systems.
Fleet & transport
Owned vehicles for raw material and finished goods movement.
Purchased electricity
HVAC for cleanrooms, process equipment, utilities, and lighting. Typically the largest Scope 2 source for pharma.
Purchased steam
Where external steam supply is used for sterilisation or process heating.
Beyond Carbon
E, S, and G — structured in the same platform.
Carbon footprint, energy consumption, water use, waste generation — all BRSR Principle 6 disclosures.
Health & safety, workforce diversity, labour practices — BRSR Principles 1–5 and CSRD ESRS S1-S4.
Corporate governance, risk management, reporting transparency — BRSR Principles 7–9.
FAQ
Pharma ESG compliance questions.
Is BRSR mandatory for pharmaceutical companies?
BRSR Principal 6 — which requires Scope 1 and Scope 2 GHG disclosure — is mandatory for the top 1000 listed companies by market capitalisation. Several large Indian pharma groups (Sun Pharma, Cipla, Dr. Reddy's, Lupin) fall within this mandate. Even for companies outside the top 1000, listed pharma companies must increasingly provide ESG data to institutional investors and ESG rating agencies.
What is the primary Scope 1 emission source for a pharma facility?
Steam boilers are typically the dominant Scope 1 source. API manufacturing facilities use large quantities of process steam for synthesis reactions, sterilisation, and HVAC across cleanroom environments. Coal and natural gas boilers are the most common fuels. Diesel generators add a secondary Scope 1 component, particularly in facilities that require 100% uptime for sterile manufacturing.
How does Sustaineve handle cleanroom HVAC electricity — is that Scope 1 or Scope 2?
Electricity consumed for cleanroom HVAC, process equipment, and facility lighting is Scope 2 — indirect energy. It is the largest energy cost and emission category for most pharma facilities. Sustaineve applies CEA state-specific grid emission factors to your DISCOM electricity bills to convert kWh to tCO2e. If you generate electricity from on-site diesel or gas, that generation is Scope 1.
Where does GMP (Good Manufacturing Practice) intersect with ESG reporting?
GMP documentation discipline creates a natural advantage for ESG data collection. Pharma facilities that maintain rigorous batch records, utility logs, and equipment maintenance records already have the raw data Sustaineve needs. The challenge is aggregating it into an ESG-structured format — which Sustaineve handles. GMP-compliant operations typically have the cleanest Scope 1 and Scope 2 data of any manufacturing sector.
Audit-ready ESG compliance for pharma manufacturing.
First compliance report within one week of onboarding.
Request Demo